11. CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE. (12th November 2021) Authors: Rahman, Rifaquat; Trippa, Lorenzo; Lee, Eudocia Quant; Arrillaga-Romany, Isabel; Touat, Mehdi; Fell, Geffrey; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. CTNI-55. THE CDK4/6 INHIBITOR ABEMACICLIB IN PATIENTS WITH RECURRENT MENINGIOMA AND OTHER PRIMARY CNS TUMORS. (12th November 2021) Authors: Coffee, Elizabeth; Panageas, Katherine; Young, Robert; Morrison, Tara; Daher, Ahmad; Grommes, Christian; Gavrilovic, Igor T; Lin, Andrew; Miller, Alexandra; Schaff, Lauren; Daras, Mariza; DeAngelis, Lisa; Diamond, Eli; Piotrowski, Anna; Malani, Rachna; Nolan, Craig; Pentsova, Elena; Santomasso, B... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. CTNI-64. FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER PENETRANCE TO ENABLE CELL-FREE DNA (CFDNA) AS A LIQUID BIOPSY IN RECURRENT PRIMARY BRAIN TUMORS. (14th November 2022) Authors: Miller, Alexandra; Ramamurthy, Bhaskar; Pike, Luke; Keralapura, Mallika; Hofius, Jonathan; Marshall, Jack; Jones, Marvin; Lee, Chi-Yin; Stember, Joseph; Brennan, Cameron; Kaley, Thomas; Dittamore, Ryan; Mellinghoff, Ingo Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. (4th February 2014) Authors: Kaley, Thomas; Barani, Igor; Chamberlain, Marc; McDermott, Michael; Panageas, Katherine; Raizer, Jeffrey; Rogers, Leland; Schiff, David; Vogelbaum, Michael; Weber, Damien; Wen, Patrick Journal: Neuro-oncology Issue: Volume 16(2014)Supplement 6 Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients. Issue 5 (3rd November 2015) Authors: Zhang, Myron; Gulotta, Bryanna; Thomas, Alissa; Kaley, Thomas; Karimi, Sasan; Gavrilovic, Igor; Woo, Kaitlin M.; Zhang, Zhigang; Arevalo-Perez, Julio; Holodny, Andrei I.; Rosenblum, Marc; Young, Robert J. Journal: Neuro-oncology Issue: Volume 18:Issue 5(2016:May) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (20th November 2020) Authors: Zadeh, Gelareh; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim;... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (9th November 2020) Authors: Nayak, Lakshmi; Molinaro, Annette; Peters, Katherine; Clarke, Jennifer; Jordan, Justin; de Groot, John; Nghiemphu, Phioanh; Kaley, Thomas; Colman, Howard; McCluskey, Christine; Gaffey, Sarah; Smith, Timothy; Cote, David; Severgnini, Mariano; Yearley, Jennifer; Zhao, Qing; Blumenschein, Wendy; Dud... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. NIMG-72. PROGNOSTIC VALUE OF [18F]-FDG POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH RECURRENT GLIOBLASTOMA RECEIVING BEVACIZUMAB. (11th November 2019) Authors: Graham, Maya; Krebs, Simone; Bale, Tejus; Domfe, Kwaku; Lobaugh, Stephanie; Zhang, Zhigang; Dunphy, Mark; Kaley, Thomas; Young, Robert Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. Issue 1 (18th August 2018) Authors: Huang, Raymond Y; Bi, Wenya Linda; Weller, Michael; Kaley, Thomas; Blakeley, Jaishri; Dunn, Ian; Galanis, Evanthia; Preusser, Matthias; McDermott, Michael; Rogers, Leland; Raizer, Jeffrey; Schiff, David; Soffietti, Riccardo; Tonn, Jörg-Christian; Vogelbaum, Michael; Weber, Damien; Reardon, David ... Journal: Neuro-oncology Issue: Volume 21:Issue 1(2019) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma. (17th September 2018) Authors: Modelevsky, Lisa; Tizon, Richard; Reiss, Samantha N; Smith, Marcel; Garonce, Rachel; Kaley, Thomas Journal: CNS oncology Issue: Volume 7:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗